Adding these inhibitors to immunotherapy increases the risk of thyroid dysfunction, especially in patients who already have autoantibodies against this organ.
Scientists from Nagoya University have found that the use of tyrosine kinase inhibitors (TKIs) in combination with anti-PD-L1 drugs is associated with greater thyroid toxicity compared with anti-PD-L1 monotherapy. In more than 700 patients who received either regimen, the incidence of … + read more
According to the Spanish Society of Medical Oncology (SEOM), about 6,000 new cases of thyroid cancer will be diagnosed in 2023. + more
Thyroid cancer is the ninth most common tumor in the world; an estimated 6,000 new cases will be diagnosed in Spain in 2023. + more
Combination therapy provides 78% disease control in patients with multiple prior treatments and metastatic disease. + read more
A link has been found between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk of thyroid cancer, thus documenting what was until now a hypothesis. + read more
CMT is one of the rarest forms of thyroid cancer, accounting for approximately three percent of all cases. + read more
Antiangiogenic therapy in patients with osimertinib-resistant tumors is more effective than immunotherapy or chemotherapy. + read more
He The average electricity price for tomorrow, November 9, 2024, will be €110.46 per megawatt…
Last week, Apple introduced its new Mac mini desktop computers. A mini-computer format that is…
Ancelotti assured that he has already identified the areas that Real Madrid need to improve…
“Today, I have come to the point where I felt comfortable wearing clothes and trusted…
At least 62 people have been arrested and five injured in Amsterdam this morning after…
Breast cancer is a heterogeneous disease that goes by many names. Advances in oncology in…